about
Pulse pressure is a strong predictor of cardiovascular risk: Data of the risk factors in impaired glucose tolerance for atherosclerosis and diabetes and the Sofia Metabolic Syndrome studies.Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies.Oral glucose tolerance test: to be or not to be performed?The metabolic syndrome in Bulgaria.Prevalence and type of dyslipidaemia in a population at risk for cardiovascular death in Bulgaria.Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance.Physical activity is strongly inversely related to post-challenge plasma glucose and glycemic spikes in a risk population for type 2 diabetes.Leukocyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population for diabetes.Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance.Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis.Fluctuations in glycaemia in clinical diabetes mellitus type 2 are not associated with carotid intima-media thickening.Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide.Relationship of physical activity and eating behaviour with obesity and type 2 diabetes mellitus: Sofia Lifestyle (SLS) study.Circulating chemerin decreases in response to a combined strength and endurance training.Effects of supervised vs non-supervised combined aerobic and resistance exercise programme on cardiometabolic risk factors.
P50
Q33445043-AC2320B4-783B-45E9-9DBE-A5AC1BCDCC31Q33728315-97246DA8-259D-496D-958D-0FA76636D1E9Q34588514-666D2002-41F3-4E41-8922-32DD3B64FFCDQ38019537-6187E316-B83E-43EF-B04A-B31BC2B4D59FQ43294197-A20EF548-C351-432D-9C76-6C5820857986Q43654161-530233BD-D7A8-4272-94B2-D19C927AE509Q44155590-2AB2A8B1-B5BF-4DC2-9E68-72583C6F603CQ44179397-8552D033-720B-4AFC-931F-EEF2057265A3Q44189225-604691C6-1495-4238-9175-DC7A90687227Q44289309-DF3C38AD-006B-40C3-A6B7-48A36E8C2C86Q44836881-738C6F70-3632-4574-A98E-9BB077737DD6Q45050542-6794FA59-63A3-4D81-B0CA-D23813A5C601Q46817502-9841A371-5160-4700-8C90-7413ABE78521Q47868741-3303E0A1-0ED1-4196-BFD3-9D44B3B19F22Q48132107-286C801C-C7FC-456D-878E-EF39347470D5Q50893712-FBB3DE13-806E-4EA1-818B-5E2711375276Q50931887-EC9F0895-5275-498C-8E8A-369AB56FFF64
P50
name
Theodora Temelkova-Kurktschiev
@ast
Theodora Temelkova-Kurktschiev
@en
Theodora Temelkova-Kurktschiev
@es
Theodora Temelkova-Kurktschiev
@nl
type
label
Theodora Temelkova-Kurktschiev
@ast
Theodora Temelkova-Kurktschiev
@en
Theodora Temelkova-Kurktschiev
@es
Theodora Temelkova-Kurktschiev
@nl
altLabel
Theodora S Temelkova-Kurktschiev
@en
Theodora S. Temelkova-Kurktschiev
@en
prefLabel
Theodora Temelkova-Kurktschiev
@ast
Theodora Temelkova-Kurktschiev
@en
Theodora Temelkova-Kurktschiev
@es
Theodora Temelkova-Kurktschiev
@nl